-transparent.png){kind=logo}
We established 2 monoclonal antiidiotypic antibodies that reacted not only with a private idiotope on human antithyroglobulin antibody but also with the Fc portion of human IgG. These antiidiotypic antibodies (B2 and B6) bound to IgG F(ab')2 antithyroglobulin derived from a patient with chronic thyroiditis and normal human IgG, but did not bind to IgG F(ab')2 nonantithyroglobulin derived from the patient and normal human IgG F(ab')2. The antiidiotypic properties and the rheumatoid factor (RF) like properties of B2 and B6 were confirmed by inhibition assay. Our results suggest that RF may be produced as antiidiotypic antibodies specific for other antigens than IgG.
Related Publications
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
November 1986,
Journal of medical microbiology,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
March 2022,
Analytical biochemistry,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
May 1986,
The Journal of experimental medicine,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
August 1993,
Annals of the New York Academy of Sciences,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
April 1995,
Hybridoma,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
February 1985,
The Journal of allergy and clinical immunology,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
May 2007,
Clinical chemistry,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
January 1992,
La Revue du praticien,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
June 1989,
Cancer research,
K Kojima, and
T Yamada, and
S Ohgaki, and
H Tanaka
December 2014,
Monoclonal antibodies in immunodiagnosis and immunotherapy,
